Levoxigram (Levofloxacin)

Levofloxacin works by binding to bacterial enzymes DNA gyrase (topoisomerase II) and topoisomerase IV. These enzymes are essential for DNA replication and transcription. Inhibiting them prevents the bacteria from copying and repairing their DNA, leading to bacterial cell death and clearance of the infection.

The specific dose of Levoxigram is determined by the prescribing healthcare professional based on the type and severity of the infection, the patient’s renal function, age, and other clinical factors. Dosage regimens may vary, and the prescriber will provide the appropriate instructions for each individual case.

Safety data for levofloxacin in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and alternatives with their healthcare provider.

To order Levoxigram, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials, then respond with pricing, availability, shipping details and any required import documentation.

Levoxigram (levofloxacin) is a third‑generation fluoroquinolone offering once‑daily dosing and a broad spectrum against Gram‑negative and Gram‑positive bacteria. Compared with older fluoroquinolones such as ciprofloxacin, it often provides higher tissue penetration and a more convenient dosing schedule, but shares similar safety considerations, including tendon‑related risks and QT prolongation.

Levoxigram should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Levoxigram is taken orally, usually with a full glass of water. It can be taken with or without food, but if antacids or mineral supplements are required, they should be spaced at least two hours apart to avoid reducing drug absorption. Follow the prescriber’s instructions for timing and duration of therapy.

Serious adverse reactions to Levoxigram include tendon rupture or inflammation, QT‑interval prolongation that can lead to life‑threatening arrhythmias, severe hypersensitivity reactions such as Stevens‑Johnson syndrome, Clostridioides difficile‑associated colitis, and peripheral neuropathy. Patients should seek immediate medical attention if they experience sudden joint pain, palpitations, rash, or neurological symptoms.

Levoxigram should be avoided in individuals with a known hypersensitivity to levofloxacin or other fluoroquinolones, those with a history of tendon disorders related to fluoroquinolone use, patients with a prolonged QT interval, and anyone currently taking medications that significantly interact with levofloxacin without appropriate monitoring.